Skystar Bio-Pharmaceutical Company news

   Watch this stock
Showing stories 1 - 10 of about 30   

Articles published

SKBI 0.160 0.000 (0.00%)
price chart
Stock Displaying Signs of a Downtrend: Skystar Bio Pharmaceutical Company ...
Shares of Skystar Bio Pharmaceutical Company (NASDAQ:SKBI) have been on a consistent downtrend as of late, causing concern for stock owners.
Accounts Payable For Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) Stood At ...
For the annual period ended 2014-09-30, Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI)reported $9.4004 millions in accounts payables.
SKYSTAR BIO PHARAMACEUTICAL COMPANY (OTCMKTS:SKBI) Short Interest Increased ...  Consumer Eagle
Skystar Bio Pharmaceutical Company: Undervalued With A Strong Growth Catalyst
Skystar Bio Pharmaceutical Company (OTCPK:SKBI) represents an interesting potential investment opportunity. The company provides niche products for China's animal husbandry industry.
Related articles »  
The major shareholder of Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI ...
John Gregory is the major shareholder of Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) 0.158 0.00 0.00% . He lately purchased 35,000 shares in the company with the transaction value amounting to approx.
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI)'s major shareholder John ...
In a document that's submitted to the U.S. SEC, it was revealed that the major shareholder of Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) 0.150 0.00 0.00% John Gregory, an insider in focus, made purchase via broker for 38,730 shares of the ...
Skystar Bio-Pharmaceutical Company (SKBI) Stock Market News
Skystar Bio-Pharmaceutical Company (SKBI), a China-based manufacturer and distributor of veterinary medicine said that its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q for the quarters ended March 31, 2015 and June 30, 2015 will not ...
Skystar Bio-Pharmaceutical Announces Final Delisting From Nasdaq and Continued ...
XI'AN, CHINA--(Marketwired - Feb 26, 2016) - Skystar Bio-Pharmaceutical Company ( OTC PINK : SKBI), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, announced that The Nasdaq Stock ...
Accounts Payable For Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) Reach $9 ...
For the quarter ended 2014-09-30 and the full year ended 2014-09-30, Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) stated that it had accounts payable of $9.4004 million and $9.4004 million, respectively.
Skystar Bio-Pharmaceutical to File Financial Results for First Quarter of ...
XI'AN, CHINA--(Marketwired - May 15, 2014) - Skystar Bio-Pharmaceutical Company ( NASDAQ : SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, will file ...
Related articles »  
Skystar Bio-Pharma (SKBI) to Delist from Nasdaq
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, announced that on December 17, 2015, Skystar Bio-Pharmaceutical Company (the ...